Lucintel's latest market report analyzed that diabetes device provides attractive opportunities in the hospitals, homecare, and diagnostic centers. The diabetes device market is expected to reach $XX billion by 2028 with a CAGR of 12% to 14%. In this market, Insulin delivery device is the largest segment by product type, whereas hospital is largest by end use industry.

Download Brochure of this report by clicking on https://www.lucintel.com/diabetes-device-market.aspx

Based on product type, the diabetes device market is segmented into blood glucose monitoring and insulin delivery devices. The Insulin delivery devices segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to unhealthy lifestyles, technological advancement in insulin delivery devices like insulin pens, insulin pumps, jet injectors, and other devices, and more people are using insulin patches, and smart insulin pumps to self-manage their diabetes.

Browse in-depth TOC on “Diabetes Device Market”

XX – Tables

XX – Figures

150 – Pages

The Diabetes Device Market is marked by the presence of several big and small players. Some of the prominent players offering diabetes device include Abbott Laboratories, Arkray, B. Braun Melsungen AG, Dexcom, F. Hoffmann-La Roche AG, Medtronic PLC, Sinocare, Nova Biomedical, Sanofi, and Novo Nordisk.

Request Sample Report:

https://www.lucintel.com/diabetes-device-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.